Trial intelligence / Profile preview

SQUEEZE Bio-Test Study in rheumatoid arthritis

NL-OMON58143Not yet recruiting

Sponsor
Queen Mary University of London
Start
Sep 2025
Countries
1
01

Overview

Open-label trial in rheumatoid arthritis (RA) (3 arms), sponsored by Queen Mary University of London. Primary endpoint: Clinical Disease Activity Index at 16 weeks. Planned start Sep 2025; status: not yet recruiting.

02

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NL-OMON58143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON58143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call